Panchsheel Organics Ltd
BSE:531726
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
124.55
214.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Panchsheel Organics Ltd
Operating Income
Panchsheel Organics Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Panchsheel Organics Ltd
BSE:531726
|
Operating Income
₹146.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹67.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹60.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹130.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Operating Income
₹51.6B
|
CAGR 3-Years
168%
|
CAGR 5-Years
35%
|
CAGR 10-Years
7%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹31.9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
Panchsheel Organics Ltd
Glance View
Panchsheel Organics Ltd. engages in the manufacture of pharmaceuticals and medicinal chemical products. The company is headquartered in Mumbai, Maharashtra. The firm's products include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression, fitness and healthcare products, and product development and testing laboratory. The firm offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone and Leflunomide. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and drosperinone. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder and Phytosterol.
See Also
What is Panchsheel Organics Ltd's Operating Income?
Operating Income
146.9m
INR
Based on the financial report for Jun 30, 2025, Panchsheel Organics Ltd's Operating Income amounts to 146.9m INR.
What is Panchsheel Organics Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
15%
Over the last year, the Operating Income growth was -11%. The average annual Operating Income growth rates for Panchsheel Organics Ltd have been 2% over the past three years , 15% over the past five years , and 15% over the past ten years .